Who are Isotonic crystalloids's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Dextrose 5% in water (D5W), Balanced crystalloid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/isotonic-crystalloids.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Isotonic crystalloids — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Isotonic crystalloids (Isotonic crystalloids) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid / Crystalloid solution. Area: Critical Care / Emergency Medicine / Perioperative Medicine.

marketed Intravenous fluid / Crystalloid solution Critical Care / Emergency Medicine / Perioperative Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Isotonic crystalloids (Isotonic crystalloids) — Marie Kristine Jessen, MD. Isotonic crystalloids restore intravascular volume and maintain electrolyte balance by providing a physiologically balanced solution of water and electrolytes that distributes across body fluid compartments.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Isotonic crystalloids TARGET	Isotonic crystalloids	Marie Kristine Jessen, MD	marketed	Intravenous fluid / Crystalloid solution
Dextrose 5% in water (D5W)	Dextrose 5% in water (D5W)	Hospital for Special Surgery, New York	marketed	Intravenous fluid / Crystalloid solution
Balanced crystalloid	Balanced crystalloid	National Taiwan University Hospital	marketed	Intravenous fluid / Crystalloid solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid / Crystalloid solution class)

Hospital for Special Surgery, New York · 1 drug in this class
Marie Kristine Jessen, MD · 1 drug in this class
National Taiwan University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Isotonic crystalloids — Competitive Intelligence Brief. https://druglandscape.com/ci/isotonic-crystalloids. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing